Article Versions Notes

Abdel-Fatah TMA, Ali R, Sadiq M, Moseley PM, Mesquita KA, Ball G, Green AR, Rakha EA, Chan SYT, Madhusudan S. ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast Cancers. Cancers. 2019; 11(8):1149. https://doi.org/10.3390/cancers11081149

Abdel-Fatah, Tarek M. A., Reem Ali, Maaz Sadiq, Paul M. Moseley, Katia A. Mesquita, Graham Ball, Andrew R. Green, Emad A. Rakha, Stephen Y. T. Chan, and Srinivasan Madhusudan. 2019. "ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast Cancers" Cancers 11, no. 8: 1149. https://doi.org/10.3390/cancers11081149

Abdel-Fatah, T. M. A., Ali, R., Sadiq, M., Moseley, P. M., Mesquita, K. A., Ball, G., Green, A. R., Rakha, E. A., Chan, S. Y. T., & Madhusudan, S. (2019). ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast Cancers. Cancers, 11(8), 1149. https://doi.org/10.3390/cancers11081149